logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Dihydropyridine Calcium Channel Blocker class drugs

    FiltersReset Filters
    25 results

    • amlodipine and olmesartan medoxomil

      (AMLODIPINE and OLMESARTAN medoxomil)
      Macleods Pharmaceuticals Limited
      Usage: Amlodipine and olmesartan medoxomil tablets are indicated for the treatment of hypertension, either alone or in combination with other antihypertensive agents, to lower blood pressure and reduce cardiovascular event risks, including strokes and heart attacks. They may also serve as initial therapy for patients needing multiple agents.

    • amlodipine besylate

      (AMLODIPINE BESYLATE)
      Cipla USA Inc.
      Usage: Amlodipine besylate is indicated for treating hypertension to reduce the risk of cardiovascular events and for managing chronic stable angina, vasospastic angina, and angiographically documented coronary artery disease (CAD) to minimize hospitalization and the need for coronary revascularization.

    • amlodipine besylate

      (AMLODIPINE BESYLATE)
      Epic Pharma, LLC
      Usage: Amlodipine Besylate Tablets are indicated for treating hypertension, chronic stable angina, vasospastic angina, and to reduce hospitalization risk in patients with documented coronary artery disease. It can be used alone or with other antihypertensive or antianginal agents to manage cardiovascular risk.

    • amlodipine besylate and olmesartan medoxomil

      (Amlodipine besylate and Olmesartan medoxomil)
      Ajanta Pharma USA Inc.
      Usage: Amlodipine and olmesartan medoxomil tablets are indicated for hypertension treatment, either alone or with other antihypertensives, to reduce blood pressure and the risk of cardiovascular events, such as strokes and myocardial infarctions. They may be used as initial therapy for patients likely needing multiple medications to reach blood pressure goals.

    • caduet

      (amlodipine besylate and atorvastatin calcium)
      Pfizer Laboratories Div Pfizer Inc
      Usage: CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.

    • cleviprex

      (clevipidine)
      Chiesi USA, Inc.
      Usage: Cleviprex is indicated for lowering blood pressure in situations where oral medication is not feasible or desirable.

    • exforge

      (amlodipine besylate and valsartan)
      Novartis Pharmaceuticals Corporation
      Usage: Exforge (amlodipine and valsartan) is indicated for treating hypertension to lower blood pressure, thereby reducing the risk of cardiovascular events like strokes and heart attacks. It can be used as initial therapy or for patients not adequately controlled on monotherapy. The choice should be individualized based on patient risk factors.

    • exforge hct

      (amlodipine valsartan and hydrochlorothiazide)
      Novartis Pharmaceuticals Corporation
      Usage: Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) is indicated for hypertension treatment to lower blood pressure, thereby reducing the risk of fatal and nonfatal cardiovascular events like strokes and myocardial infarctions. It is not recommended for initial hypertension therapy. Comprehensive management may require multiple medications.

    • felodipine

      (Felodipine)
      Chartwell RX, LLC

    • felodipine

      (Felodipine Extended-release Tablets)
      Yiling Pharmaceutical Inc.
      Usage: Felodipine Extended-release Tablets are indicated for treating hypertension to lower blood pressure, reducing the risk of cardiovascular events like strokes and myocardial infarctions. It can be used alongside other antihypertensive drugs as part of comprehensive cardiovascular risk management, including lifestyle modifications and additional therapies.